Rare disease advocates also want increased funding for the FDA Office of Orphan Products Development's clinical trial and natural history grant programs. • Source: File photo
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
